Product Program year 2024 Source: CMS Open Payments

TandemLife

Device Cardiology/Vascular Diseases

Open in the dashboard

General payments

$272,079

509 payments

Research payments

$0

0 payments

Through program year 2024, $272,079 in general payments and $0 in research payments were reported against TandemLife (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $3,495 1
2020 General $47,430 25
2019 General $221,154 483

Breakdown

Who paid General payments · program years 2019–2024
  1. LivaNova USA, Inc. $272,079 509 payments
Top recipients General payments · program year 2020
  1. Karl Kern Cardiovascular Disease · Tucson, AZ $18,895 40% · 12 payments
  2. Aditya Bansal Thoracic Surgery (Cardiothoracic Vascular Surgery) · New Orleans, LA $10,235 22% · 4 payments
  3. Rajan Patel Interventional Cardiology · New Orleans, LA $8,455 18% · 4 payments
  4. Eric Gnall Interventional Cardiology · Wynnewood, PA $3,500 7% · 2 payments
  5. Navin Kapur Cardiovascular Disease · Baltimore, MD $2,670 6% · 1 payment

The top 5 of 7 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $21,565 45% · 2 practitioners
  2. Interventional Cardiology Internal Medicine $15,630 33% · 4 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $10,235 22% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Arizona $18,895 40% · 1 recipient
  2. Louisiana $18,690 39% · 2 recipients
  3. Pennsylvania $3,500 7% · 1 recipient
  4. Massachusetts $2,670 6% · 1 recipient
  5. Missouri $2,275 5% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

509 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record